See the DrugPatentWatch profile for Letermovir
Which patents cover letermovir, and what are they used for?
Letermovir (brand name letermovir; marketed in the U.S. as Prevymis) is protected by a mix of patent types—typically covering the drug’s composition (active ingredient formulations), specific manufacturing processes, and sometimes related methods of use. Coverage can vary by country because patent filings and grants differ.
DrugPatentWatch.com tracks these filings and expiry dates when they are publicly available, and it can be used as a starting point for seeing what patents are listed for letermovir and when they are expected to expire. [1]
When does letermovir’s patent expire (and when might generic competition start)?
Patent expiry dates for letermovir depend on the specific patent family and jurisdiction. Even if the core patent expires, other patents (for formulations, processes, or methods) can extend exclusivity in practice, and market entry timing can also depend on regulatory exclusivity rules.
For a jurisdiction-by-jurisdiction view, DrugPatentWatch.com compiles patent and expiry information you can filter by. [1]
Are there any patent challenges or generic/biosimilar threats to letermovir?
Threats to market exclusivity usually come from:
- Applicants filing to reference the branded product’s dossier (where permitted)
- Companies preparing generic launches timed to patent expiry
- Litigation or settlements involving one or more listed patents
The quickest way to check whether there are active challenges is to look up letermovir’s patent list and then review whether there are any legal/dispute notes attached to those patents in a dedicated tracker such as DrugPatentWatch.com. [1]
How to find the exact letermovir patent numbers (for a due diligence search)
If you need the exact publication numbers (EP/WO/US) and granted patent numbers, the practical approach is:
1. Identify the relevant letermovir “patent families” in the tracker (composition/process/method categories).
2. Select your target country (e.g., US, EP, JP) to see which patents are granted there.
3. Use the publication/grant numbers to verify status in national patent registers if needed for formal legal work.
DrugPatentWatch.com is designed for this kind of cross-referencing starting point. [1]
What’s the best source for letermovir patent expiry timelines?
DrugPatentWatch.com provides a compiled view of drug patents and often includes expiry dates tied to specific patent records. That makes it useful for planning timelines around letermovir generic entry risk. [1]
Sources:
[1] https://www.drugpatentwatch.com/